Millennium Management
TARA icon

Millennium Management’s Protara Therapeutics TARA Stock Holding History

Millennium Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.8M Buy
2,831,208
+2,077,906
+276% +$12.3M 0.01% 1801
2025
Q4 		$4.02M Buy
753,302
+65,046
+9% +$362K ﹤0.01% 3257
2025
Q3 		$2.99M Buy
688,256
+124,136
+22% +$402K ﹤0.01% 3666
2025
Q2 		$1.71M Sell
564,120
-4,301
-0.8% -$14.8K ﹤0.01% 4015
2025
Q1 		$2.42M Buy
568,421
+196,968
+53% +$880K ﹤0.01% 3602
2024
Q4 		$1.96M Buy
371,453
+357,051
+2,479% +$1.15M ﹤0.01% 3663
2024
Q3 		$26.4K Buy
+14,402
New +$29.6K ﹤0.01% 5768
2024
Q1 		– Sell
-11,506
Closed -$21.5K – 6648
2023
Q4 		$21.5K Sell
11,506
-6,541
-36% -$9.64K ﹤0.01% 5619
2023
Q3 		$30.1K Sell
18,047
-6,501
-26% -$14.9K ﹤0.01% 5571
2023
Q2 		$58.7K Sell
24,548
-1,773
-7% -$5.27K ﹤0.01% 5443
2023
Q1 		$82K Sell
26,321
-3,305
-11% -$10.9K ﹤0.01% 5486
2022
Q4 		$79K Sell
29,626
-20,581
-41% -$65K ﹤0.01% 5649
2022
Q3 		$149K Sell
50,207
-10,577
-17% -$35.8K ﹤0.01% 5811
2022
Q2 		$178K Sell
60,784
-11,566
-16% -$42.3K ﹤0.01% 5692
2022
Q1 		$370K Sell
72,350
-33,895
-32% -$178K ﹤0.01% 5357
2021
Q4 		$717K Buy
106,245
+1,327
+1% +$9.15K ﹤0.01% 4731
2021
Q3 		$726K Sell
104,918
-24,462
-19% -$191K ﹤0.01% 4987
2021
Q2 		$1.26M Buy
129,380
+69,246
+115% +$784K ﹤0.01% 4454
2021
Q1 		$947K Buy
60,134
+4,875
+9% +$90.4K ﹤0.01% 4267
2020
Q4 		$1.34M Buy
55,259
+17,331
+46% +$374K ﹤0.01% 3531
2020
Q3 		$638 Buy
37,928
+28,698
+311% +$665K ﹤0.01% 3448
2020
Q2 		$271K Sell
9,230
-33,189
-78% -$1.03M ﹤0.01% 3713
2020
Q1 		$1M Buy
+42,419
New +$1.24M ﹤0.01% 2463
2016
Q3 		– Sell
-386
Closed -$124K – 3593
2016
Q2 		$124K Buy
+386
New +$115K ﹤0.01% 2988

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management's TARA Position: Q1 2026 in Review

Millennium Management increased its Protara Therapeutics (TARA) stake by 276% in Q1 2026, buying an estimated $12.3M and bringing the position to 2,831,208 shares worth $14.8M. The position accounts for 0.01% of the portfolio, ranked #1801.

Millennium Management first reported a position in TARA in Q2 2016 and has held it in 24 quarters since. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Millennium Management held 2,831,208 shares of Protara Therapeutics worth $14.8M as of Q1 2026.
  • Millennium Management bought 2,077,906 Protara Therapeutics shares in Q1 2026, an estimated $12.3M.
  • Protara Therapeutics made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1801 holding.
  • Millennium Management first reported a position in Protara Therapeutics in Q2 2016 and has held it in 24 quarters since.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.